Proton therapy may prolong OS in stage II, III NSCLC

Proton beam therapy improved OS compared with conventional photon-based therapy in patients with stage II/III non–small cell lung cancer, according to results of a retrospective database analysis presented at the ASCO Annual Meeting.
Healio